The oncogenic potential of three different 7,12-dimethylbenz(a)anthracene transformed C3H/10T1/2 cell clones at various passages and the importance of the mode of immunosuppression.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001551:Benz(a)Anthracenes; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D004622:Embryo, Mammalian; D005260:Female; D007109:Immunity / Q000528:radiation effects; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000209:etiology; D013601:T-Lymphocytes / Q000276:immunology; D014185:Transplantation, Isogeneic
D000961:Antilymphocyte Serum; D001551:Benz(a)Anthracenes; D015127:9,10-Dimethyl-1,2-benzanthracene